logo

Biotechnology & Drugs News

Share

Gilead Sciences Licenses Three Preclinical Antiviral Programs From Novartis

Sartorius Stedim Biotech H1 Sales Revenue Up 19.0% To EUR 709.3 Mln

Bayer, Bristol-Myers Squibb And Ono Pharmaceutical Enter Clinical Collaboration

Novartis Q2 EPS From Cont Ops $0.91 Vs $3.32 Last Year